Browse the evidence

Early weight loss (within the first 3 months) is a strong predictor of long-term (12-month) weight loss success.

Focus heavily on the first 3 months of your diet. If you achieve significant weight loss in this period, you are highly likely to maintain it long-term. Use this early success to build confidence and habits.

Self-reported depression is associated with significantly lower weight loss outcomes in dietary weight-loss programs.

If you are struggling with depression, be aware that it may make weight loss more challenging. Consider seeking support for your mental health alongside your dietary changes, as this can significantly improve your weight loss outcomes.

Genetic variants in the FTO gene increase obesity susceptibility, but this genetic risk can be reduced by approximately 30% through engagement in physical activity.

If you have a family history of obesity, do not assume you are destined to gain weight. Research shows that regular physical activity can significantly blunt the impact of common obesity genes (like FTO). Prioritize consistent exercise as a primary tool to manage your genetic risk.

Polygenic risk scores (PRS) and genetic risk scores (GRS) can identify individuals with high genetic susceptibility to obesity, allowing for targeted preventative interventions.

While PRS can identify high-risk individuals, current scores are not precise enough for individual clinical decision-making for most people. Focus on standard healthy lifestyle habits regardless of genetic testing results.

The interaction between physical activity levels and carbohydrate intake significantly influences blood glucose concentrations, with the magnitude and direction of this effect moderated by an individual's genetic risk score (GRS).

Your blood sugar response to eating carbs and exercising is not one-size-fits-all. It depends on your specific genetic makeup. While general advice holds, personalized adjustments based on your genetic risk score and activity level may be necessary for optimal glucose control.

Adherence to an imported food pattern, characterized by high consumption of processed staples and low consumption of local plant-based foods, is significantly associated with higher odds of obesity and severe obesity in Pacific Island populations.

In Tuvalu, shifting away from a diet heavy in imported processed foods (rice, noodles, sugary snacks) toward a pattern that includes more local, diverse, and plant-based foods is associated with significantly lower odds of obesity. Prioritizing local produce and reducing reliance on imported staples may help mitigate obesity rates.

Six weeks of aerobic conditioning augments the acute satellite cell content (specifically type-I fibers) and ribosome biogenesis (45S pre-rRNA, 5.8S/28S ITS) in response to acute eccentric muscle damage in young adults.

If you engage in aerobic exercise, it may prepare your muscles to repair themselves more effectively after intense, muscle-damaging workouts (like heavy eccentric lifting). Specifically, aerobic training appears to increase the number of satellite cells in slow-twitch fibers and boost the machinery (ribosomes) needed for repair. This suggests that regular cardio might enhance your muscle's ability to recover from strenuous resistance training.

Physique competitors utilize carbohydrate back-loading and water manipulation (loading/restriction) as primary nutritional peaking strategies to enhance muscle fullness and definition immediately prior to competition.

If you are competing in a physique sport, expect to use carbohydrate back-loading and water/sodium manipulation in the week before your show. Most competitors start this 7 days prior. Be aware that your strategy may need to differ based on your sex and drug status (if applicable), as enhanced athletes often restrict water more aggressively and males/professionals tend to load sodium more frequently than females/amateurs.

A short-term (7-week) supervised intervention of Time-Restricted Eating (TRE) and/or High-Intensity Interval Training (HIIT) can promote long-term self-reported maintenance of these lifestyle behaviors in women with overweight/obesity, with approximately 45-46% continuing the respective interventions two years later without ongoing supervision.

If you are overweight or obese, a short, supervised period of Time-Restricted Eating (limiting eating to 10 hours a day) or High-Intensity Interval Training (3 sessions a week) can help you build the habit to continue these behaviors on your own for years. You don't need to be perfect; maintaining the habit 5 days a week is sufficient for long-term success. The key is using the initial supervised time to learn how to fit these flexible strategies into your real life, rather than relying on constant external motivation.

Semaglutide 2.4 mg facilitates substantial, sustainable weight loss and improves cardiometabolic health by reducing 'food noise' and maladaptive eating behaviors.

Semaglutide 2.4 mg is an effective tool for reducing 'food noise' and enabling sustainable weight loss when lifestyle changes alone are insufficient. It works by altering hormonal signals related to appetite and satiety.

GLP-1RAs reduce emotional eating in the short term (3-6 months) by modulating reward processing, but this effect may not be long-lasting (12 months) and does not address underlying emotion regulation deficits.

GLP-1RAs like semaglutide can help reduce emotional eating for the first 3-6 months by changing how your brain responds to food rewards. However, this effect may fade after a year, and the medication does not fix the underlying emotional regulation skills. For lasting results, combine GLP-1RA treatment with emotion regulation therapies like CBT or DBT.

GLP-1 receptor agonists (e.g., semaglutide) and dual/triple agonists (e.g., tirzepatide) cause significant lean body mass loss (up to 40% of total weight loss), but this largely reflects reductions in non-contractile organs (liver, kidneys) rather than true skeletal muscle atrophy, with functional strength often preserved or improved.

If you are taking a GLP-1 drug like semaglutide, expect your total 'lean mass' number to drop significantly (up to 40% of weight lost). However, this is mostly water and organ mass (liver/kidneys), not your actual muscle fibers. Your strength likely stays the same or gets better because you are lighter. Focus on resistance training to maintain muscle quality, but do not panic about 'muscle wasting' as the primary driver of weight loss.

Implantation of the Duodeno-Jejunal Bypass (DJB) device for 12+ months significantly reduces body weight (mean 10.3% TBWL) and BMI in obese patients (BMI ≥ 27 kg/m2).

The DJB device, implanted endoscopically for about a year, can help obese patients lose an average of 10% of their body weight. It is less invasive than surgery but carries a risk of complications (about 13% require early removal). It is particularly useful for patients with Type 2 Diabetes as it also improves blood sugar control.

DJB implantation significantly improves glycemic control (HbA1c reduction) in patients with Type 2 Diabetes Mellitus.

For patients with Type 2 Diabetes, the DJB device can lower HbA1c levels from an average of 5.6% to 5.1% after one year. This improvement in blood sugar control is a key benefit alongside weight loss.

A personalized ketogenic diet (≤20g carbs/day) induces rapid fat loss and preserves skeletal muscle mass in the short term (3 months), but long-term adherence drops significantly after the initial phase.

Start with a strict limit of 20g carbs daily, focusing on healthy fats and moderate protein. Expect rapid fat loss in the first 3 months, but be prepared for a drop-off in motivation. To stay on track, monitor ketones, manage electrolytes to avoid 'keto flu', and work with a professional to adjust calories if weight loss stalls.

Vitamin D supplementation can suppress myostatin expression and stimulate anabolic pathways (Akt/mTOR, IGF-1), potentially aiding muscle preservation in at-risk populations.

If you are elderly or have a chronic condition, ensuring adequate Vitamin D levels may help support muscle health by influencing myostatin and anabolic pathways. Consult your doctor for appropriate dosing, as thresholds are not yet defined.

In women with overweight, consuming fresh lean beef as the primary protein source promotes healthier eating behavior by reducing voluntary carbohydrate and sugar intake compared to plant-based protein alternatives, despite similar satiety levels.

If you are trying to reduce sugar and carbs, choosing lean beef over plant-based protein alternatives might help you stick to your goals. In this study, women who ate beef voluntarily ate less sugar and carbs than those who ate plant-based proteins, likely because they enjoyed the beef more. This suggests that food preference and satisfaction play a key role in making healthier food choices.

Structured lifestyle counseling in primary care significantly improves patient outcomes, including reduced stress, enhanced treatment adherence, and better chronic disease management, by addressing psychosocial factors and promoting self-efficacy.

Integrate brief, structured lifestyle counseling into every primary care visit. Use established frameworks like the '5 A's' (Ask, Advise, Assess, Assist, Arrange) or 'FRAMES' to guide the interaction. Focus on shared decision-making and setting specific, measurable goals with the patient. Regularly monitor progress to adjust the plan. This approach improves adherence and chronic disease management without requiring extensive time or specialized therapy training.

Patients with severe obesity carrying a high genetic risk score for waist-hip ratio (WHR GRS) experience significantly reduced weight loss from a 24-week milk-based meal replacement program compared to those with lower WHR GRS.

If you have a family history of carrying weight around your waist, standard meal replacement diets might be less effective for you than for others. This doesn't mean you can't lose weight, but you may need to manage expectations regarding the speed and magnitude of loss, or consider more intensive support. Genetic testing for waist-hip ratio risk could help tailor your approach.

12 weeks of intense interval training significantly reduces the Visceral Adiposity Index (VAI) in women with Polycystic Ovary Syndrome (PCOS), but does not significantly alter serum adipose levels.

If you have PCOS, 12 weeks of high-intensity interval training (3x/week) can improve your visceral fat profile (VAI) without necessarily changing your serum adipose protein levels. Focus on the VAI improvement as a key health benefit, even if other blood markers remain stable.

In overweight and obese adults, lower serum magnesium levels are significantly associated with higher fasting blood glucose levels, independent of energy and macronutrient intake.

If you are overweight or obese, maintaining adequate magnesium levels may help manage fasting blood glucose. While this study did not test supplementation, it highlights that lower magnesium levels within the normal range are linked to higher glucose. Focus on magnesium-rich foods (nuts, seeds, leafy greens) as part of a healthy diet.

Personalized nutrition improves postprandial glycemic response (PPGR) compared to control diets, with a median mean difference of -14.85 mg/dLxh.

Personalized nutrition significantly improves postprandial glycemic response (PPGR) compared to standard diets. This means blood sugar spikes after meals are better managed with personalized advice.

Carriers of the T allele of the rs7903146 TCF7L2 polymorphism experience significantly greater reductions in body fat mass compared to CC homozygotes when treated with carbohydrate-restricted diet alone.

If you are undergoing dietary treatment for blood sugar issues, your genetic makeup (specifically the TCF7L2 gene) may determine how much body fat you lose. Those with the T allele tend to lose significantly more fat than those with the CC genotype. This suggests that personalized dietary advice based on genetics could optimize fat loss outcomes.

Homozgyous carriers of the C allele of the rs1042714 ADRB2 polymorphism experience significantly greater reductions in hip circumference compared to G allele carriers when treated with metformin and diet.

If you are taking metformin alongside a diet for blood sugar issues, your ADRB2 genetics may influence where you lose fat. Those with the CC genotype tend to reduce their hip circumference more significantly than those with the G allele. This suggests that personalized medical advice based on genetics could optimize body shape outcomes.